IMAX Corporation (IMAX) PT Raised to $25 as MKM Partners Expects to See Evidence of a Recovery in 4Q Results

February 1, 2021 8:46 AM EST
Get Alerts IMAX Hot Sheet
Price: $21.09 --0%

Rating Summary:
    9 Buy, 9 Hold, 1 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 9 | Down: 8 | New: 34
Trade Now! 
Join SI Premium – FREE

News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here.

MKM Partners analyst Eric Handler raised the price target on IMAX Corporation (NYSE: IMAX) to $25.00 (from $18.00) with the COVID recovery already underway, Asia exposure poised to support the top line and an asset light business model to convert revenue to cash. .

The analyst maintained a Buy rating, stating "In our view, IMAX's global footprint and asset light structure continue to help it navigate effectively through the COVID-pandemic. Evidence of a recovery should be seen in 4Q20 results where its exposure to Asia (55% of IMAX's screens) has positioned IMAX to achieve break-even cash flow. This exposure should also help in 1Q21, especially given what we believe will be a very strong Chinese New Year box office performance come mid-February. While we are lowering our overall box office outlook for 2021 to reflect ongoing delays with Hollywood feature film content, IMAX's ability to: (1) benefit from local language movies in a number of international markets; and (2) install systems in markets where theatres are open should result in a faster recovery than what will be seen with traditional theatre operators."

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Analyst Comments, Analyst PT Change